Clinical Trials Logo

Clinical Trial Summary

This study aim to assess the accuracy of magnetic resonance imaging (MRI) compared to gray-scale and colour Doppler ultrasound (US) for the prenatal diagnosis of placenta accreta.


Clinical Trial Description

Placenta accreta occurs when the chorionic villi abnormally invade the myometrium. Based on histopathology it is divided into three grades: placenta accreta (the chorionic villi are in contact with the myometrium), placenta increta (the chorionic villi invade the myometrium), and placenta percreta where the chorionic villi penetrate the uterine serosa. With increasing rate of cesarean delivery, the incidence of both placenta praevia and placenta accreta is steadily increasing in frequency.

Prenatal diagnosis of invasive placentation is associated with a reduced risk of maternal complications as it allows a preplanned treatment of the condition . Gray-scale and colour Doppler ultrasound (US) are valuable tools in the prenatal diagnosis of placenta accreta .However, if the ultrasound ( US ) findings suggest possible percreta or are inconclusive or negative in an at-risk woman, magnetic resonance imaging (MRI) can be useful.

Multiple sonographic findings are seen with placenta accreta such as decrease in myometrial thickness, placenta previa, placental lacunae, abnormal pattern of color Doppler, loss of the retroplacental clear zone and placenta percreta irregularities in wall of urinary bladder ( UB ) have been detected .

The most magnetic resonance imaging characteristic findings seen in placenta accreta are nodular thickening in the dark zone of placenta-uterine interface together with extensions of dark bands through the placenta, outer uterine bulge causing from the mass effect of the placenta and heterogeneous signal intensity of placenta on the T2-weighted HASTE sequences due to large placental lakes and vessels. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03813212
Study type Observational
Source Ain Shams University
Contact Safaa Thabet, M.B.B.,Ch
Phone 01067593438
Email Safaathabet63@yahoo.com
Status Recruiting
Phase
Start date January 1, 2019
Completion date January 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05376410 - Relationship Between Maternal Soluble Trigger Receptor Expressed on Myeloid Cells-1 (sTREM-1) and Placenta Accreta Spectrum
Not yet recruiting NCT05191316 - the Efficacy and Safety of the 3-steps Conservative Approach in the Management of Placenta Accreta Spectrum (a Novel Technique)
Completed NCT05945446 - A Serum Galectin-3 Levels in Placenta Accreta Spectrum Pregnancies
Recruiting NCT03947047 - Detection of Placenta Accreta Via Exhaled Women Breath
Not yet recruiting NCT05513092 - Placenta Accreta Index Score in Placenta Accreta Spectrum